Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Maurotoxin: A Potent Inhibitor of Intermediate Conductance Ca2+-Activated Potassium Channels

N. A. Castle, D. O. London, C. Creech, Z. Fajloun, J. W. Stocker and J.-M. Sabatier
Molecular Pharmacology February 2003, 63 (2) 409-418; DOI: https://doi.org/10.1124/mol.63.2.409
N. A. Castle
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. O. London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Creech
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Z. Fajloun
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. W. Stocker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.-M. Sabatier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 63 no. 2 409-418
DOI 
https://doi.org/10.1124/mol.63.2.409
PubMed 
12527813

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received June 28, 2002
  • Accepted November 12, 2002
  • Published online February 1, 2003.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. N. A. Castle1,
  2. D. O. London1,
  3. C. Creech1,
  4. Z. Fajloun2,
  5. J. W. Stocker1 and
  6. J.-M. Sabatier2
  1. 1Icagen Inc., Durham, North Carolina (N.A.C., D.O.L., C.C., J.W.S.); and 2Centre National de la Recherche Scientifique, Unité Mixte Recherche 6560, l'Institut Fédératif de Recherches Jean Roche, Marseille, France (Z.F., J.-M.S.)
  1. Neil A. Castle, Ph.D., Icagen Inc., 4222 Emperor Boulevard, Suite 350, Durham, NC 27703. E-mail:ncastle{at}icagen.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: January 2003 to August 2022

AbstractFullPdf
Jan 2003428093
Feb 2003146365
Mar 2003144935
Apr 2003114228
May 200364534
Jun 200333025
Jul 200372311
Aug 200311239
Sep 200372616
Oct 200392418
Nov 2003123017
Dec 2003183012
Jan 2004112815
Feb 200492514
Mar 2004203326
Apr 200492010
May 200492413
Jun 2004165632
Jul 2004174311
Aug 2004163418
Sep 200493210
Oct 200420488
Nov 2004123313
Dec 20049199
Jan 2005105718
Feb 2005204315
Mar 2005123721
Apr 200552313
May 20059329
Jun 200582213
Jul 20058178
Aug 200551915
Sep 200561916
Oct 200511178
Nov 2005102113
Dec 20057147
Jan 20066166
Feb 200642214
Mar 20068203
Apr 200641613
May 20062115
Jun 20065127
Jul 20066144
Aug 20068139
Sep 2006452
Oct 20063119
Nov 20066246
Dec 200631511
Jan 20071227
Feb 200751610
Mar 20071106
Apr 2007111619
May 2007112018
Jun 200781210
Jul 2007274
Aug 200761210
Sep 2007274
Oct 20075128
Nov 20074175
Dec 2007043
Jan 20080157
Feb 20080118
Mar 20084107
Apr 2008857
May 20083102
Jun 20085179
Jul 200852415
Aug 200818247
Sep 20086185
Oct 20086156
Nov 2008112419
Dec 20082153
Jan 20096227
Feb 2009662
Mar 20091466
Apr 2009859
May 20097117
Jun 200931614
Jul 200921712
Aug 2009585
Sep 2009975
Oct 2009768
Nov 2009447
Dec 2009335
Jan 201013812
Feb 2010111512
Mar 2010265
Apr 2010477
May 20101124
Jun 20102125
Jul 201017115
Aug 2010365
Sep 2010768
Oct 201022013
Nov 20106124
Dec 20102139
Jan 20116714
Feb 2011122313
Mar 201191516
Apr 201151115
May 20114167
Jun 20119204
Jul 201110814
Aug 20116911
Sep 201161812
Oct 201151724
Nov 201141810
Dec 201101414
Jan 201231311
Feb 20122169
Mar 2012111021
Apr 201291615
May 20129816
Jun 20122118
Jul 201210158
Aug 201282410
Sep 201210219
Oct 201291113
Nov 20126179
Dec 201241416
Jan 20138104
Feb 20132911
Mar 201331410
Apr 2013131621
May 20135106
Jun 2013245
Jul 2013577
Aug 20133622
Sep 2013723
Oct 2013433
Nov 20138410
Dec 20131016
Jan 201410710
Feb 2014649
Mar 201481619
Apr 201412424
May 2014268
Jun 20141334
Jul 20146106
Aug 201491112
Sep 20142912
Oct 20141073
Nov 20141089
Dec 20141367
Jan 2015576
Feb 201531428
Mar 2015442
Apr 2015745
May 20156116
Jun 201511114
Jul 20153126
Aug 20155162
Sep 20158939
Oct 2015429
Nov 201571211
Dec 2015749
Jan 20161269
Feb 20161856
Mar 2016101214
Apr 201641012
May 2016575
Jun 20167716
Jul 20166819
Aug 201611015
Sep 201611116
Oct 2016372
Nov 20163114
Dec 20160108
Jan 201711215
Feb 201754313
Mar 20170317
Apr 20171144
May 20170113
Jun 20170112
Jul 20170115
Aug 20171144
Sep 20171139
Oct 20170163
Nov 20170175
Dec 20170148
Jan 20180176
Feb 201822815
Mar 20181108
Apr 20180198
May 201802611
Jun 20180109
Jul 201801016
Aug 2018085
Sep 20180173
Oct 20181138
Nov 20180104
Dec 20181470
Jan 20191301
Feb 20191741
Mar 20191812
Apr 20192111
May 20191511
Jun 20191504
Jul 20192410
Aug 20192350
Sep 20191422
Oct 20191831
Nov 20191632
Dec 20192531
Jan 2020900
Feb 20201200
Mar 2020412
Apr 20202324
May 20201751
Jun 20201972
Jul 20201600
Aug 2020203
Sep 2020720
Oct 20202010
Nov 20201301
Dec 20201630
Jan 20211351
Feb 20214253
Mar 20212510
Apr 20211266
May 2021721
Jun 20213550
Jul 2021710
Aug 2021720
Sep 2021640
Oct 20211331
Nov 20212540
Dec 20213233
Jan 20222710
Feb 20221410
Mar 2022320
Apr 2022710
May 20221121
Jun 20221043
Jul 20221121
Aug 2022500

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 63 (2)
Molecular Pharmacology
Vol. 63, Issue 2
1 Feb 2003
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Maurotoxin: A Potent Inhibitor of Intermediate Conductance Ca2+-Activated Potassium Channels
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Maurotoxin: A Potent Inhibitor of Intermediate Conductance Ca2+-Activated Potassium Channels

N. A. Castle, D. O. London, C. Creech, Z. Fajloun, J. W. Stocker and J.-M. Sabatier
Molecular Pharmacology February 1, 2003, 63 (2) 409-418; DOI: https://doi.org/10.1124/mol.63.2.409

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Maurotoxin: A Potent Inhibitor of Intermediate Conductance Ca2+-Activated Potassium Channels

N. A. Castle, D. O. London, C. Creech, Z. Fajloun, J. W. Stocker and J.-M. Sabatier
Molecular Pharmacology February 1, 2003, 63 (2) 409-418; DOI: https://doi.org/10.1124/mol.63.2.409
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • α-Conotoxin Binding Site on the GABAB Receptor
  • Upacicalcet binds to the amino acid binding site of CaSR
  • Characterization of GRD and LCCH3 from Human Louse
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics